Semaglutide Injection 4mg/3ml PFS Manufacturer

Product Overview

Sanjar Pharma manufactures Semaglutide Injection 4mg/3ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, controlled cleanroom environments, and comprehensive quality systems designed to support product consistency and regulatory compliance.

Semaglutide is a GLP-1 Receptor Agonist widely recognized within the specialty injectable pharmaceutical segment. The prefilled syringe format provides a ready-to-use dosage presentation that supports administration efficiency, dosing accuracy, and streamlined handling across healthcare settings.

Manufactured under strict sterile conditions and supported by advanced analytical testing, microbiological monitoring, and quality assurance systems, Sanjar Pharma supplies Semaglutide Injection to pharmaceutical companies, distributors, healthcare institutions, procurement agencies, and international pharmaceutical markets.